CD53 and neoplasm: Aptamer-siRNA chimeras have already been used effectively in xenografted mice to target particular oncogenes for knockdown only in cancer cells (using an aptamer designed for EpCAM, a cell surface antigen that is highly expressed in most epithelial cancers) in order to suppress tumor growth [53].